(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Adicet Bio's earnings in 2025 is -$117,320,000.On average, 3 Wall Street analysts forecast ACET's earnings for 2025 to be -$93,188,934, with the lowest ACET earnings forecast at -$100,905,743, and the highest ACET earnings forecast at -$82,709,625. On average, 3 Wall Street analysts forecast ACET's earnings for 2026 to be -$84,090,876, with the lowest ACET earnings forecast at -$91,807,684, and the highest ACET earnings forecast at -$71,957,374.
In 2027, ACET is forecast to generate -$88,912,847 in earnings, with the lowest earnings forecast at -$89,326,395 and the highest earnings forecast at -$88,499,299.